600479.SH
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 9.80
+0.41%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 11.48
From 52W high−33.83%
Volume48.29M
Market capCNY 4.82B
P/E (TTM)16.9x
P/S (TTM)1.6x
Div yield3.27%
Key dataSep 18, 2026
Open
CNY 11.48
From 52W high
−33.83%
Volume
48.29M
Market cap
CNY 4.82B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
10.2x
P/E (TTM)
16.9x
RSI (14)
49.0
MomentumView details →
1D Return
+0.41%
YTD Return
+14.37%
Similar companies
Latest newsMore news →
Qianjin Pharmaceutical announced a cash dividend of 1.8 yuan per 10 shares (tax included).26d agoQianjin Pharmaceutical's subsidiaries received drug registration certificates from China's National Medical Products Administration for four drugs, including Minoxidil Tincture, Ezetimibe Tablets, Amlodipine Benazepril Capsules, and Ursodeoxycholic Acid Capsules.34d agoQianjin Pharmaceutical's subsidiary Hunan Qianjin Xiangjiang Pharmaceutical received a drug registration certificate for Baclofen Tablets from the National Medical Products Administration.62d ago